BridgeMD
New treatment option for Health-Related Quality-of-Life
Official title Cocreating Action to Improve Rationality in the Health System
ClinicalTrials.gov ID: NCT07237971
What this study is testing
- What it's testing
- Despite widespread recognition of social, economic, or environmental health determinants, health action remains heavily dominated by individual-level solutions (e.g., medication, patient counselling, vaccination). This study aims to stimulate changes in health system functioning by demonstrating how the cocreation of actions to address psychological well-being, cardiovascular health, and antimicrobial resistance from within the community can alleviate the burden on primary care services, reduce medicalisation and increase health equity.
- Time commitment: about 3 years
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Survey general population: A representative population survey of adult (aged 18 years and over) who are residents in the Municipal District 2 of...
- Group 1 (Antidepressants and Anxiolytics): N05B, N05C, N06A.
- Group 2 (Cardiovascular disease risk factor medication): A10B (antidiabetics), C10A (cholesterol-lowering drugs), C07A, C09A, C03C, C08C...
- Group 3 (Antibiotics): J01 Health service data from primary care: A series of aggregate indicators will be collected from the electronic information...
- People aged 18 and over who are residents or have a job or family connection in the Municipal District 2 of Elche (Spain) who are interested in...
See the full eligibility criteria
- Survey general population: A representative population survey of adult (aged 18 years and over) who are residents in the Municipal District 2 of Elche (Spain). Survey community pharmacies: Individuals who visit the...
- Group 1 (Antidepressants and Anxiolytics): N05B, N05C, N06A.
- Group 2 (Cardiovascular disease risk factor medication): A10B (antidiabetics), C10A (cholesterol-lowering drugs), C07A, C09A, C03C, C08C (antihypertensives).
- Group 3 (Antibiotics): J01 Health service data from primary care: A series of aggregate indicators will be collected from the electronic information systems of the regional health authorities (Conselleria de Sanidad de...
- People aged 18 and over who are residents or have a job or family connection in the Municipal District 2 of Elche (Spain) who are interested in participating, wish to be actively involved in the co-creation, planning...
- Representatives from community institutions and associations, including professionals from the Elche Public Health Center, primary care teams in the area, Elche Council staff, as well as professionals and volunteers...
The study team makes the final eligibility decision.
Where it's taking place
- Elche, Alicante, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 3 years per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Elche, Alicante, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.